Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

There is little information about the clinical effectiveness of cefepime and piperacillin-tazobactam in the treatment of infections caused by extended-spectrum β-lactamase (ESBL)-producing pathogens. Some inferences have been drawn from laboratory studies, which have usually involved only one or a f...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Thomson, Kenneth S., Moland, Ellen Smith
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90867/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709338/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3548-3554.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!